Completed Research

Since 2001, the Center for Women's Health Research has been supporting principal investigators through the pre-award and post-award process. The following is a list of completed awards by category. Learn more about the history of CWHR here, as well as the Center's current projects here.

View completed research by:

(Click on heading below to expand)

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012

 

Efficacy & Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women w/Atrophic Vaginitis

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 12/13/2005 to 12/13/2008

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009

 

A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. John Thorp, Obstetrics and Gynecology
  • 10/24/2006 to 8/1/2010

 

The Effect of Dose Titration And Dose Tapering On The Tolerability of DVS SR In Women With Vasomotor Symptoms

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/30/2007 to 1/28/2010

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007

 

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010

 

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011

 

Engaging Low income Urban Residents in Prioritizing Interventions to Address the Socio-Economic Determinants of Health

  • NIH Clinical Center
  • Dr. Joanne Garrett, Obstetrics and Gynecology
  • 9/4/2007 to 9/30/2008

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012

 

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013

 

Time to Conceive

  • National Institute of Child Health and Human Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012

 

A Pilot Study of Early Postpartum Intrauterine Contraception

  • Society of Family Planning
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 7/2/2009 to 4/1/2011

 

A randomized, double-blind, placebo-controlled, dose-ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and the pharmacokinetics of GSK221149A administered orally in healthy, pregnant females with incomplicated pre-term labor between 300/7-356/7 weeks gestation

  • SmithKline Beecham Pharmaceuticals
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/25/2009 to 8/24/2012

 

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012

 

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012

Pudendal Nerve Function as a Predictor of Female Sexual Function with Sacral Neuromodulation

  • American Urogynecologic Society Foundation
  • Dr. Elizabeth Geller, Obstetrics and Gynecology
  • 1/1/2010 to 3/30/2011

 

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010

 

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010

 

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012

 

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012

 

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013

 

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012

 

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

    • American Medical Systems
    • Dr. Catherine Matthews, Obstetrics and Gynecology
    • 9/14/2010 to 9/13/2013

 

Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Study

      • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), subscontract to University of Alabama at Birmingham
      • Dr. Kim Boggess, Obstetrics and Gynecology
      • 9/20/2010 to 7/31/2014

 

HIV and Drug Use in Georgian Women

    • NIH National Institute on Drug Abuse (NIDA)
    • Dr. Hendree Jones, Obstetrics and Gynecology, UNC Horizons
    • 9/30/2010 to 6/30/2015

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013

 

FMR1 CGG Repeats In Primary Ovarian Insufficiency Women vs. 2 Comparison Groups

  • University of Virginia
  • Dr. Steven Young, Obstetrics and Gynecology
  • 9/15/2011 to 6/30/2014

Pharmacokinetics, pharmacodynamics, and genital tract viral shedding in HIV+ women using combined oral contraceptives and raltegravir

  • Merck Sharp and Dohme
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 5/30/2012 to 3/29/2014

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013


Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013


Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013


A Transgenerational e-Intervention for Gestational Diabetics and their Offspring

  • NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 4/1/2013 to 3/31/2015

Manual liquid based cytology

  • chemQ Bioscience
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 4/1/2013 to 09/30/2013

Reinforced Treatment for Pregnant Drug Abusers (Home II)

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 6/1/2013 to 5/31/2014
(Click on heading below to expand)

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016 (currently administered by OBGYN)

 

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011

 

Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Study

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), subscontract to University of Alabama at Birmingham
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/20/2010 to 7/31/2014

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012

Pelvic Floor Disorders Network Data Coordinating Center

  • Research Triangle Institute
  • Dr. AnnaMarie Connolly, Obstetrics and Gynecology
  • 8/1/2011 to 6/30/2014

Engaging Low income Urban Residents in Prioritizing Interventions to Address the Socio-Economic Determinants of Health

  • NIH Clinical Center
  • Dr. Joanne Garrett, Obstetrics and Gynecology
  • 9/4/2007 to 9/30/2008

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013

LIFE: LivSure for Fecal Incontinence. A clinical evaluation of LivSure vaginal bowel control (VBC) device for the treatment of fecal incontinence in women.

  • Pelvalon, Inc
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 3/7/2013 to 5/2014

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010

 

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010

 

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012

A Transgenerational e-Intervention for Gestational Diabetics and their Offspring

  • NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 4/1/2013 to 3/31/2015

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013

Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013


Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013

Reinforced Treatment for Pregnant Drug Abusers (Home II)

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 6/1/2013 to 5/31/2014

 

HIV and Drug Use in Georgian Women

  • NIH National Institute on Drug Abuse (NIDA)
  • Dr. Hendree Jones, Obstetrics and Gynecology, UNC Horizons
  • 9/30/2010 to 6/30/2015

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013

Manual liquid based cytology

  • chemQ Bioscience
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 4/1/2013 to 09/30/2013

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007

 

A Pilot Study of Early Postpartum Intrauterine Contraception

  • Society of Family Planning
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 7/2/2009 to 4/1/2011

Pharmacokinetics, pharmacodynamics, and genital tract viral shedding in HIV+ women using combined oral contraceptives and raltegravir

  • Merck Sharp and Dohme
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 5/30/2012 to 3/29/2014

Time to Conceive

  • National Institute of Child Health and Human
  • Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013

 

Efficacy & Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women w/Atrophic Vaginitis

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 12/13/2005 to 12/13/2008

 

A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. John Thorp, Obstetrics and Gynecology
  • 10/24/2006 to 8/1/2010

 

The Effect of Dose Titration And Dose Tapering On The Tolerability of DVS SR In Women With Vasomotor Symptoms

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/30/2007 to 1/28/2010

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010

 

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009

 

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012

 

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013

A randomized, double-blind, placebo-controlled, dose-ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and the pharmacokinetics of GSK221149A administered orally in healthy, pregnant females with incomplicated pre-term labor between 300/7-356/7 weeks gestation

  • SmithKline Beecham Pharmaceuticals
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/25/2009 to 8/24/2012

 

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012

FMR1 CGG Repeats In Primary Ovarian Insufficiency Women vs. 2 Comparison Groups

  • University of Virginia
  • Dr. Steven Young, Obstetrics and Gynecology
  • 9/15/2011 to 6/30/2014
(Click on heading below to expand)

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009

Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012

Manual liquid based cytology

  • chemQ Bioscience
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 4/1/2013 to 09/30/2013

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013

 

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013

 

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010

Reinforced Treatment for Pregnant Drug Abusers (Home II)

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 6/1/2013 to 5/31/2014

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013

 

Time to Conceive

  • National Institute of Child Health and Human Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012

 

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012

 

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016 (currently administered by OBGYN)

 

Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Study

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), subscontract to University of Alabama at Birmingham
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/20/2010 to 7/31/2014

A Transgenerational e-Intervention for Gestational Diabetics and their Offspring

  • NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 4/1/2013 to 3/31/2015

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010

Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013

A Pilot Study of Early Postpartum Intrauterine Contraception

  • Society of Family Planning
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 7/2/2009 to 4/1/2011

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012

FMR1 CGG Repeats In Primary Ovarian Insufficiency Women vs. 2 Comparison Groups

  • University of Virginia
  • Dr. Steven Young, Obstetrics and Gynecology
  • 9/15/2011 to 6/30/2014
Some awards may be listed under more than one category. (Click on heading below to expand)

 

Efficacy & Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women w/Atrophic Vaginitis

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 12/13/2005 to 12/13/2008

 

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009

 

A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. John Thorp, Obstetrics and Gynecology
  • 10/24/2006 to 8/1/2010

 

The Effect of Dose Titration And Dose Tapering On The Tolerability of DVS SR In Women With Vasomotor Symptoms

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/30/2007 to 1/28/2010

 

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007

 

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010

 

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009

 

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012

 

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013

 

LIFE: LivSure for Fecal Incontinence. A clinical evaluation of LivSure vaginal bowel control (VBC) device for the treatment of fecal incontinence in women.

  • Pelvalon, Inc
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 3/7/2013 to 5/2014

Pharmacokinetics, pharmacodynamics, and genital tract viral shedding in HIV+ women using combined oral contraceptives and raltegravir

  • Merck Sharp and Dohme
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 5/30/2012 to 3/29/2014

Manual liquid based cytology

  • chemQ Bioscience
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 4/1/2013 to 09/30/2013

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007

 

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010

 

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

 

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012

Pharmacokinetics, pharmacodynamics, and genital tract viral shedding in HIV+ women using combined oral contraceptives and raltegravir

  • Merck Sharp and Dohme
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 5/30/2012 to 3/29/2014

Time to Conceive

  • National Institute of Child Health and Human Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012

A Transgenerational e-Intervention for Gestational Diabetics and their Offspring

  • NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 4/1/2013 to 3/31/2015

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009

 

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013

A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. John Thorp, Obstetrics and Gynecology
  • 10/24/2006 to 8/1/2010

The Effect of Dose Titration And Dose Tapering On The Tolerability of DVS SR In Women With Vasomotor Symptoms

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/30/2007 to 1/28/2010

 

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010

 

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013

 

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012

 

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013

 

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011

 

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009

 

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012

 

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013

 

A randomized, double-blind, placebo-controlled, dose-ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and the pharmacokinetics of GSK221149A administered orally in healthy, pregnant females with incomplicated pre-term labor between 300/7-356/7 weeks gestation

  • SmithKline Beecham Pharmaceuticals
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/25/2009 to 8/24/2012

 

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012

 

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010

 

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012

 

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013

 

Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Study

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), subscontract to University of Alabama at Birmingham
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/20/2010 to 7/31/2014

FMR1 CGG Repeats In Primary Ovarian Insufficiency Women vs. 2 Comparison Groups

  • University of Virginia
  • Dr. Steven Young, Obstetrics and Gynecology
  • 9/15/2011 to 6/30/2014

Engaging Low income Urban Residents in Prioritizing Interventions to Address the Socio-Economic Determinants of Health

  • NIH Clinical Center
  • Dr. Joanne Garrett, Obstetrics and Gynecology
  • 9/4/2007 to 9/30/2008

 

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012

 

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013


Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013


Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013

Reinforced Treatment for Pregnant Drug Abusers (Home II)

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 6/1/2013 to 5/31/2014

 

HIV and Drug Use in Georgian Women

  • NIH National Institute on Drug Abuse (NIDA)
  • Dr. Hendree Jones, Obstetrics and Gynecology, UNC Horizons
  • 9/30/2010 to 6/30/2015

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013


Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013


Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016 (currently administered by OBGYN)

 

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010

Pudendal Nerve Function as a Predictor of Female Sexual Function with Sacral Neuromodulation

  • American Urogynecologic Society Foundation
  • Dr. Elizabeth Geller, Obstetrics and Gynecology
  • 1/1/2010 to 3/30/2011

 

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013

 

LIFE: LivSure for Fecal Incontinence. A clinical evaluation of LivSure vaginal bowel control (VBC) device for the treatment of fecal incontinence in women.

  • Pelvalon, Inc
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 3/7/2013 to 5/2014